Table 1.
First author and year | Study population and setting | Modelling method | Categorisation of harm from errors | Outcome measures |
---|---|---|---|---|
Karnon, (2008) [21] | Inpatients of a 400-bed acute hospital in the UK | Decision tree | No harm, minor, moderate and severe/life-threatening harm |
Incremental costs of correcting an error detected before administration, and treating the adverse effects of an error including extra tests, treatments and hospital length of stay Monetary valuation of QoL reduction following a harmful error |
Lahue, (2012) [2] | Hospital inpatients receiving injectable medicines in the USA | Not specifically named, but effectively a decision tree | Harm and no harm | Incremental cost of a harmful medication error |
Samp, (2014) [22] | Primary, secondary and tertiary care patients in the USA | Decision tree | 8 categories from combining: temporary, permanent or no harm; hospitalisation; treatment required; death | Incremental costs of the error, including monitoring and those arising from permanent harm |
QoL quality of life